Connection
Vijayalakshmi Nandakumar to Antibodies, Antiphospholipid
This is a "connection" page, showing publications Vijayalakshmi Nandakumar has written about Antibodies, Antiphospholipid.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.273 |
|
|
|
-
Dadelahi A, Walker BS, Banerjee D, Mahler M, Saadalla A, Nandakumar V. Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome. J Appl Lab Med. 2025 May 02; 10(3):605-618.
Score: 0.947
-
Saadalla A, Novis CL, Banerjee D, Martins T, Holloway B, Ann Aure M, Mahler M, Nandakumar V. Comparative assessment of the diagnostic performances of particle-based multianalyte technology and commercial ELISA for antiphospholipid autoantibody testing. Clin Chim Acta. 2024 Aug 15; 562:119849.
Score: 0.895
-
Saadalla A, Nandakumar V. Anti-phosphatidyl-serine/prothrombin (aPS/PT) antibodies are superior predictors of LAC presence and APS diagnoses: A single center study. Clin Chim Acta. 2024 Feb 01; 554:117761.
Score: 0.216
-
Zhang XS, Bizzaro N, Tebo AE, Nandakumar V, Infantino M, Carbone T, Bossuyt X, Damoiseaux J. Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research. Immunol Res. 2024 06; 72(3):361-363.
Score: 0.215